Guru Ownership Trend
Guru Analysis for Pyxis Oncology, Inc. (PYXS)
Pyxis Oncology, Inc. (PYXS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.36 M.
Top institutional holders include Renaissance Technologies (RenTech) and Steven Cohen.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $335,199.56 net outflow during the quarter.
Recent activity highlights Steven Cohen who increased their stake by 15.9%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 13.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Pyxis Oncology, Inc. (PYXS)
Major holders include Renaissance Technologies (RenTech) ($2.32 M), Steven Cohen ($111,647). According to the latest reported data, 2 tracked investment managers collectively hold approximately 809,324 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $335,199.56, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited PYXS. The total reported sell value was $350,508.43.
Yes, 0 managers opened new positions in PYXS, and 1 increased their existing holdings. The total reported buy value was $15,308.87.